Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions.
about
Perspectives for Monocyte/Macrophage-Based Diagnostics of Chronic InflammationCrystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development.Survey of the year 2000 commercial optical biosensor literature.Establishment of a quantitative PCR system for discriminating chitinase-like proteins: catalytically inactive breast regression protein-39 and Ym1 are constitutive genes in mouse lungLong term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation.HLA class II is associated with distal interphalangeal osteoarthritisCancer risk by combined levels of YKL-40 and C-reactive protein in the general populationChitinase-like proteins in lung injury, repair, and metastasisIs YKL-40 a new therapeutic target in cancer?Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis.YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?Plasma YKL-40: a potential new cancer biomarker?Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury.Joint and bone assessment in hand osteoarthritis.New treatment and markers of prognosis for idiopathic pulmonary fibrosis: lessons learned from translational research.Role of chitinase-like proteins in cancer.Investigation of the Levels of Serum Amyloid A, YKL-40, and Pentraxin-3 in Patients with Familial Mediterranean Fever.Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial.Quantitative Real-Time PCR Analysis of YKL-40 and Its Comparison with Mammalian Chitinase mRNAs in Normal Human Tissues Using a Single Standard DNA.YKL-40 and its complex association with metabolic syndrome, obesity, and cardiovascular diseaseChitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients.Ultrasonographic evaluation of the femoral cartilage thickness in patients with systemic lupus erythematosus.Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation.Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice.Association of serum YKL-40 with the presence and severity of obstructive sleep apnea syndrome.Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.Toll-like receptors: a new target in rheumatoid arthritis?
P2860
Q26745913-904F504A-7106-4062-910E-06684B727653Q27641650-54E49CC3-B23E-4217-8E6B-1244C473589DQ30596758-20BC3B02-DF32-4484-B6D7-27A268EF0898Q34464911-5959245B-893E-4DD8-BC2A-8C66BE6CFFE4Q35311500-14554FB2-C1D1-46B7-9BC3-51C5E427201BQ35551481-9DFF3738-D4C2-4524-A1E5-A8FDB054D8D3Q35552435-F4F5D916-6BF9-416A-9364-7F6D34031081Q35653750-E7F0855B-84CA-40E8-8E92-6753209394C8Q35984042-D4D419D7-1B77-4D86-BF73-98991D896B01Q36709555-F64CF316-3A76-4DF0-A9B3-8B855D87DDF4Q36913222-060DAD4D-27A7-48F1-A0B5-A79F36099D7DQ37334247-D86726B9-548F-4048-8C31-FFBF4783DF0CQ37605869-E718D547-13ED-4D19-AC19-A39063B93148Q37807414-0B779560-5BEF-42E9-BA0D-E1C1E5DDE2F4Q38150213-B7D8A154-CB5D-4E67-8B38-C7F14E0BA49EQ38153815-945A3884-4A9D-4F24-83E9-044CCBC96596Q38687563-EB9DE35D-F4BF-40FA-A6AC-A0D68E63DF72Q40082880-652B4DE3-5F12-4CCF-BA09-1A4D496E71C9Q41422799-F57AA3F8-1CC3-4C64-B62D-4AE65D3CF1C9Q41523077-96801404-6B80-45E7-8E53-85F799C226A1Q42271209-EDFA762B-A83B-408E-AD53-97EDA9929E87Q42320020-0A809218-2EF8-402C-849E-8DD27CAABF2AQ42372237-86D0DCEE-1995-4855-8F16-878455B94F83Q43793905-469FA30F-40FE-4424-B771-C5C15A347923Q44559401-8A40467C-E82D-48BE-81ED-C88326E1D801Q47855094-43432B32-09A5-4B0B-972B-40DFDC61AA75Q48092406-A3A46D8D-4679-4290-BB35-967DE21CB9A2Q48269484-E9C7753B-2B0F-4473-9D8E-3FFC8C4344B0Q53614685-7C7E2B69-1DE2-4F32-9904-1E29F7B434A6
P2860
Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Raised human cartilage glycopr ...... other inflammatory conditions.
@ast
Raised human cartilage glycopr ...... other inflammatory conditions.
@en
type
label
Raised human cartilage glycopr ...... other inflammatory conditions.
@ast
Raised human cartilage glycopr ...... other inflammatory conditions.
@en
prefLabel
Raised human cartilage glycopr ...... other inflammatory conditions.
@ast
Raised human cartilage glycopr ...... other inflammatory conditions.
@en
P2093
P2860
P356
P1476
Raised human cartilage glycopr ...... other inflammatory conditions.
@en
P2093
A M Miltenburg
F C Breedveld
M W van Den Heuvel
P Steenbakkers
R A van Hogezand
R R de Vries
P2860
P304
P356
10.1136/ARD.59.7.544
P407
P577
2000-07-01T00:00:00Z